ArriVent BioPharma (NASDAQ:AVBP) Research Coverage Started at B. Riley
B. Riley initiated coverage on shares of ArriVent BioPharma (NASDAQ:AVBP – Free Report) in a research note issued to investors on Thursday, MarketBeat reports. The brokerage issued a buy rating and a $37.00 price target on the stock. A number of other brokerages have also recently issued reports on AVBP. HC Wainwright reaffirmed a “buy” […]
B. Riley initiated coverage on shares of ArriVent BioPharma (NASDAQ:AVBP – Free Report) in a research note issued to investors on Thursday, MarketBeat reports. The brokerage issued a buy rating and a $37.00 price target on the stock. A number of other brokerages have also recently issued reports on AVBP. HC Wainwright reaffirmed a “buy” […]
